Anal fistula is a painful colorectal condition that affects hundreds of thousands of people worldwide
An anal fistula is an artificial tunnel between the rectum and skin of the buttocks that can develop due to an infected or blocked anal gland. If left untreated, an abscess may form, and the infection may travel through the patient’s sphincter muscle. Patients and their physicians are dissatisfied with current treatment options, which frequently result in inadequate or slow healing, a high risk of fecal incontinence, and repeat procedures.
A breakthrough for patients with anal fistula
Patients endure a poor quality of life, experiencing pain, suffering and discharge from the tract and related abscesses.
Patients and their physicians are dissatisfied with current treatment options, which are not effective for curing anal fistula.
Current treatments have generally poor results, with many carrying the risk of causing permanent incontinence, inadequate healing, and repeat surgeries
There are 64,000 annual surgical procedures performed to treat anal fistula in the U.S. alone.
A GROUNDBREAKING IMPLANT DESIGNED TO PREVENT REINFECTION AND PROMOTE HEALING
Featuring a bioabsorbable implant, BioHealx™ technology is designed to:
Securely close and heal the fistula tract, dissolving in the body after treatment.
Prevent reinfection, protect continence, and drastically improve patients' quality of life.
Reduce complications and lower the cost of treatment for patients, and for the healthcare system as a whole.
BioHealx™ is an investigational, minimally invasive technology designed to offer a single-operation, effective solution for healing anal fistulas, eliminating the need for patients
to undergo multiple procedures.
The BioHealx™ is an investigational device not currently approved in the United States or in the European Union. Its use is limited to investigational use in clinical trials.
WE ARE DEVELOPING NOVEL MINIMALLY INVASIVE TECHNOLOGIES TO TREAT COLORECTAL DISEASES
Signum Surgical is committed to developing innovative solutions to treat patients with colorectal diseases, starting with anal fistula. After a year of exploring the needs of gastrointestinal and colorectal care, Eoin Bambury and Moshe Zilversmit founded the company in 2016 as a spin-out of the National University of Ireland, Galway, BioInnovate programme. The company is headquartered in Galway, Ireland.
CO-FOUNDER / CEO
Medical device entrepreneur with over 12 years of experience in medical device development. Moshe released the world's first open source surgical device, which has been covered by Wired magazine and recognised by Discover Magazine as one of the top innovations of 2013.
CO-FOUNDER / CTO
Over 19 years of experience in the research and development of novel medical devices. Eoin has contributed to the development of six medical devices currently on the market and is a named author on 11 patent filings. Eoin was awarded 'Chartered Engineer of the Year 2012' by Engineers Ireland.
& BOARD CHAIRMAN
Jeff is an intellectual property specialist with more than 25 years of experience in early stage medtech companies. Jeff previously served as a Managing Partner at successful incubator The Foundry and holds a JD from the University of Washington and a BS in Mechanical Engineering from Stanford.
Alan brings more than 40 years of experience in the medical device industry. Alan is involved with multiple life science companies as a CEO and as a board member and was a Senior Advisor to Frazier Healthcare Partners. Alan is an expert in bioabsorbable materials and the inventor of Vicryl, an absorbable surgical suture.
Declan brings 20 years of leadership experience in the medical device industry, focused on products and technologies for minimally invasive procedures. He has specialized in product and technology transfer management. Declan's core degree is in Mechanical Engineering. He is an active supporter of medical device start-up companies.
STAY UP TO DATE WITH THE LATEST NEWS FROM SIGNUM SURGICAL
SUPPORT & INVESTORS
WANT TO WORK WITH US?
We are hiring!
email us at:
NEW DOCKS, THE DOCKS, GALWAY
Developing Minimally Invasive Technologies to Treat Colorectal Diseases
1. Ommer A et al: Clinical practice guideline: Cryptoglandular anal fistula. Dtsch Arztebl Int 2011; 108(42): 707–13.